ArticleLeukemia & lymphoma2019

Non-NAD-like PARP1 inhibitor enhanced synthetic lethal effect of NAD-like PARP inhibitors against BRCA1-deficient leukemia.

Margaret Nieborowska-Skorska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.